There is a moment in 2009 that, in hindsight, changed the trajectory of modern medicine. Derrick Rossi, a stem cell biologist at Harvard Medical School, was working late in his lab on a problem that had fascinated — and frustrated — scientists for decades: how to reprogram adult human cells to behave like embryonic stem […]
The Untold Story of Moderna: From a Harvard Lab to the Arms of Billions Read More »
Every year, LexisNexis publishes a list that the financial and scientific world tends to treat as a quiet but credible report card on global innovation. The Top 100 Global Innovators ranking does not measure press releases or funding rounds or how many times a CEO appeared on a podcast. It is built on something harder
Boston Places Five Companies on the World’s Most Exclusive Innovation List Read More »
There is a company headquartered in Boston that manages more money than the GDP of every country on earth except the United States and China. It employs more than 78,000 people. It administers $17.5 trillion in assets and oversees $6.8 trillion in discretionary investments. It processes millions of trades every single day, manages retirement accounts
While most of the tech world spent the first weeks of 2026 announcing layoffs, Boston’s WHOOP went in the opposite direction. On March 4, the Kenmore Square-based wearable health company announced it would add more than 600 new employees over the course of the year — a move that would increase its current workforce of
Wearable tech company WHOOP Is Hiring 600 People. Boston Should Pay Attention Read More »
There is a number that has come to define ambition in the startup world: one billion dollars. The threshold that separates a promising company from a unicorn — a privately held startup valued at $1 billion or more. The term was coined in 2013 by venture capitalist Aileen Lee, who at the time identified just
The Rise of the Boston Unicorn: Which Companies Are Next? Read More »
The FDA doesn’t always say no with a single word — sometimes it sends a letter. But for Watertown-based Disc Medicine, the Complete Response Letter it received this month for its lead drug bitopertin had the same effect: a hard stop that forced the company to rethink its near-term future, and to part ways with
Disc Medicine Cuts One in Five Jobs After FDA Rejects Bitopertin Application Read More »
There is a stretch of Cambridge, Massachusetts — barely a square mile in size — that has quietly become the most consequential piece of real estate in global science. On any given morning, the Red Line deposits researchers, entrepreneurs, venture capitalists, and executives from companies like Moderna, Biogen, Google, and Takeda onto the same sidewalks.
The Kendall Square Effect: The Most Valuable Square Mile in Science Read More »
Wall Street opened Monday on shaky ground as investors scrambled to reassess their portfolios in response to a new wave of conflict in the Middle East involving Iran. The market reaction was swift and telling: energy companies surged, defense contractors rallied, while airlines, cruise operators, and luxury brands took a sharp hit. Brent crude oil
Global Markets Rattled as Iran Conflict Sends Energy and Defense Stocks Soaring Read More »
If anyone was looking for a sign that Massachusetts’ economic engine is running at full power, the end of February 2026 has dispelled any doubts. In just 28 days, startups in Greater Boston have managed to raise nearly $1 billion in funding rounds, a “treasure trove” that positions the region as a leader in highly
February Closes with Nearly $1 Billion Invested in Boston Startups Read More »
The recent intensification of the conflict in Iran has ceased to be a foreign policy news story and has become a cash flow concern for Massachusetts businesses. Following the latest attacks and the threat of a shutdown at key energy logistics hubs, the price of a barrel of oil has reacted with a volatility unseen
The Escalation in the Middle East and the New Cost Ceiling for Boston Read More »
